Yabao Pharmaceutical Group Co. Ltd. (600351)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
6. 91
-0.05
-0.7184%
¥
4.32B Market Cap
- P/E Ratio
0.6% Div Yield
30.9M Volume
- Eps
¥ 6.96
Previous Close Want to track 600351 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Yabao Pharmaceutical Group Co. Ltd. (600351) Statistics
Valuation metrics
Market Cap 4.32B
Enterprise value 3.83B
Trailing P/E (ttm) 14.89
Forward P/E -
PEG ratio 0.38
Price/Sales (ttm) 2.1
Price/Book (mrq) 1.67
Enterprise Value/Revenue 1.71
Enterprise Value/EBITDA 8
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 29.66M
Average volume (90 days) 16.4M
Price summary
52-Week low 5.6
52-Week high 7.97
Beta -
50-Day moving average 6.36
200-Day moving average 6.52
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.35
Trailing annual dividend yield 0.0513%
5-Year annual dividend yield -
Payout ratio 0.75
Dividend Date 15 Jun 2026
Ex-Dividend Date 15 Jun 2026
Last split factor 2:1
Last split Date 28 May 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.14%
Operating margin 0.13%
Operational effectiveness
Return on assets 0.1%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.24
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.47
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.33
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 3.81%
Book value per share (mrq) 3.99
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
